相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1
Jesus Romero-Pozuelo et al.
CELL REPORTS (2020)
The broken cycle: E2F dysfunction in cancer
Lindsey N. Kent et al.
NATURE REVIEWS CANCER (2019)
Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast Cancer
Chrysiis Michaloglou et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
Andrea Ghelli Luserna Di Rora et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
Omer Schwartzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells
Xinhui Zhou et al.
SCIENTIFIC REPORTS (2017)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA
H-D Chae et al.
LEUKEMIA (2015)
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
Trudy D. Buitenkamp et al.
BLOOD (2014)
Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003
David O'Connor et al.
BLOOD (2014)
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol
Katharine Patrick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation
Andrew A. Lane et al.
NATURE GENETICS (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features
Claire J. Schwab et al.
HAEMATOLOGICA (2013)
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
Josephine Aimiuwu et al.
BLOOD (2012)
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21
Anindita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Defective Hematopoietic Stem Cell and Lymphoid Progenitor Development in the Ts65Dn Mouse Model of Down Syndrome: Potential Role of Oxidative Stress
Laureanne Pilar E. Lorenzo et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles
M. G. Loudin et al.
LEUKEMIA (2011)
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
Libi Hertzberg et al.
BLOOD (2010)
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Lisa J. Russell et al.
BLOOD (2009)
Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia
Amos Gaikwad et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
Charles G. Mullighan et al.
NATURE GENETICS (2009)
IRF8 regulates B-cell lineage specification, commitment, and differentiation
Hongsheng Wang et al.
BLOOD (2008)
A small-molecule E2F inhibitor blocks growth in a melanoma culture model
Yihong Ma et al.
CANCER RESEARCH (2008)
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Dani Bercovich et al.
LANCET (2008)
Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities
Zhongyou Li et al.
HUMAN MOLECULAR GENETICS (2007)
Risks of leukaemia and solid tumours in individuals with Down's syndrome
H Hasle et al.
LANCET (2000)
分享论文
